The nonhospital costs of care of patients with CF in The Netherlands: Results of a questionnaire

European Respiratory Journal

Volumn 9, Issue 11, 1996, Pages 2215-2219

  Wildhagen, M F ^a,f   Verheij, J B G M ^b   Verzijl, J G ^a   Gerritsen, J ^c   Bakker, W ^d   Hilderink, H B M ^a   Ten Kate, L P ^e   Tijmstra, T ^b   Kooij, L ^b   Habbema, J D F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEYENBURG HOSPITAL   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Costs of care; Cystic fibrosis; Home care; The Netherlands

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FLUCLOXACILLIN; INSULIN; IPRATROPIUM BROMIDE; MESNA; MUCOLYTIC AGENT; PANCREAS ENZYME; PANCREATIN; PANCRELIPASE; RANITIDINE; SALBUTAMOL; TOBRAMYCIN; URSODEOXYCHOLIC ACID; VITAMIN;

ACUPUNCTURE; ADULT; ARTICLE; CHILD; CYSTIC FIBROSIS; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOMEOPATHY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NETHERLANDS; ORAL DRUG ADMINISTRATION; PANCREAS INSUFFICIENCY; PHYSIOTHERAPIST; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION;

ABSENTEEISM; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; CYSTIC FIBROSIS; DRUG THERAPY; EQUIPMENT AND SUPPLIES; FOOD, FORTIFIED; HEALTH CARE COSTS; HOME NURSING; HUMANS; INFANT; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; TRANSPORTATION;

EID: 10344266453     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09112215     Document Type: Article

References (14)

1. ten Kate LP. Cystic fibrosis in The Netherlands. Int J Epidemiol 1977; 6(1): 23-34.
2. Gerritsen J, van der Laag H, Sinnema G, Knol K. Guidance of children and adolescents with cystic fibrosis. Lung 1990; 168: 474-480.
3. Verzijl JG, Hilderink HBM, Verheij JBGM, Kooij L, Habbema JDP, ten Kate LP. Costs of cystic fibrosis (CF) and costs of screening for CF carriers in The Netherlands. In: Escobar H, Baquero F, Suárez L, eds. Clinical Ecology of Cystic Fibrosis. Madrid, Exerpta Medica, Elsevier Science Publishers B.V., 1993; pp. 313-318.
4. Rutten FFH, van Ineveld BM, van Ommen R, van Hout BA, Huijsman R. Kostenberekening bij gezondheidszorgonderzoek; richtlijnen voor de praktijk. Instituut voor Medische Technology Assessment, 1993.
5. Statistics Netherlands. Monthly bulletin of health statistics. Statistics Netherlands, 1994; Vol. 13, No. 94/5.
6. Tamm M, Higenbottam T. Heart-lung and lung transplantation for cystic fibrosis: world experience. Semin Respir Crit Care Med 1994; 15: 414-425.
7. Mylett J, Johnson K, Knowles M. Alternate therapies for cystic fibrosis. Semin Respir Crit Care Med 1994; 15: 426-433.
8. Wilson JM. Cystic fibrosis: strategies for gene therapy. Semin Respir Crit Care Med 1994; 15: 439-445.
9. Rosenstein BJ. Cystic fibrosis in the year 2000. Semin Respir Crit Care Med 1994; 15: 446-451.
10. Wildhagen MF, Verheij JBGM, Hilderink HBM, et al. Costs of care of patients with cystic fibrosis in The Netherlands in 1990-1991. Thorax 1996; 51(3): 298-301.
11. ten Kate LP, Halley DJJ. Genetische aspecten van "cystic fibrosis". Tijdschr Huisartsgeneeskd 1995; 12: 195-198.
12. Bakker W, Vinks AATMM, Mouton JW, de Jonge P, Verzijl JG, Heijerman HGM. Continue intraveneuze thuisbehandeling van luchtweginfecties met ceftazidim via een draagbare pomp bij patiënten met cystische fibrose; een multicentrisch onderzoek. Ned Tijdschr Geneeskd 1993; 137: 2486-2491.
13. Wildhagen MF, Hilderink HBM, Verzijl JG, et al. Costs, effects and savings of screening for CF gene carriers. (Submitted 1996).
14. Health Council of the Netherlands. Committee on Genetic Screening. Genetic screening. The Hague, Health Council, 1994; No. 1994/22E.